{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:15:10Z","timestamp":1759778110364,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim (US)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-016-0348-y","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T01:19:53Z","timestamp":1454635193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region"],"prefix":"10.1186","volume":"15","author":[{"given":"Ildiko","family":"Toma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Harnish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"issue":"24","key":"348_CR1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMe0904090","volume":"360","author":"WE Boden","year":"2009","unstructured":"Boden WE, Taggart DP. Diabetes with coronary disease\u2014a moving target amid evolving therapies? N Engl J Med. 2009;360(24):2570\u20132. doi: 10.1056\/NEJMe0904090 .","journal-title":"N Engl J Med"},{"issue":"17","key":"348_CR2","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIR.0000000000000094","volume":"130","author":"DM Maahs","year":"2014","unstructured":"Maahs DM, Daniels SR, de Ferranti SD, Dichek HL, Flynn J, Goldstein BI, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014;130(17):1532\u201358. doi: 10.1161\/CIR.0000000000000094 .","journal-title":"Circulation"},{"key":"348_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12933-015-0204-5","volume":"14","author":"L Cea Soriano","year":"2015","unstructured":"Cea Soriano L, Johansson S, Stefansson B, Rodriguez LA. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14:38. doi: 10.1186\/s12933-015-0204-5 .","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"348_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1753944715594528","volume":"9","author":"F Angeli","year":"2015","unstructured":"Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis. 2015;9(6):412\u201324. doi: 10.1177\/1753944715594528 .","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"4","key":"348_CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pop.2014.08.002","volume":"41","author":"K Mercier","year":"2014","unstructured":"Mercier K, Smith H, Biederman J. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors. Prim Care. 2014;41(4):765\u201378. doi: 10.1016\/j.pop.2014.08.002 .","journal-title":"Prim Care"},{"issue":"1","key":"348_CR6","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2337\/dc15-S011","volume":"38","author":"American Diabetes A. (8)","year":"2015","unstructured":"American Diabetes A. (8). Cardiovascular disease and risk management. Diabetes Care. 2015;38(1):S49\u201357. doi: 10.2337\/dc15-S011 .","journal-title":"Diabetes Care"},{"issue":"4","key":"348_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMc081065","volume":"359","author":"N Buchner","year":"2008","unstructured":"Buchner N, Banas B, Kramer BK. Telmisartan, ramipril, or both in patients at high risk of vascular events. N Engl J Med. 2008;359(4):426. doi: 10.1056\/NEJMc081065 .","journal-title":"N Engl J Med"},{"issue":"19","key":"348_CR8","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","volume":"351","author":"AH Barnett","year":"2004","unstructured":"Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004;351(19):1952\u201361. doi: 10.1056\/NEJMoa042274 .","journal-title":"N Engl J Med"},{"issue":"5","key":"348_CR9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","volume":"43","author":"SC Benson","year":"2004","unstructured":"Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension. 2004;43(5):993\u20131002. doi: 10.1161\/01.HYP.0000123072.34629.57 .","journal-title":"Hypertension"},{"issue":"6","key":"348_CR10","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0735-1097(00)00958-X","volume":"36","author":"DS Fieno","year":"2000","unstructured":"Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36(6):1985\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"348_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCIMAGING.110.960591","volume":"4","author":"R Dash","year":"2011","unstructured":"Dash R, Chung J, Ikeno F, Hahn-Windgassen A, Matsuura Y, Bennett MV, et al. Dual manganese-enhanced and delayed gadolinium-enhanced MRI detects myocardial border zone injury in a pig ischemia-reperfusion model. Circ Cardiovasc Imaging. 2011;4(5):574\u201382. doi: 10.1161\/CIRCIMAGING.110.960591 .","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"348_CR12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.113.008157","volume":"130","author":"D Elverfeldt von","year":"2014","unstructured":"von Elverfeldt D, Maier A, Duerschmied D, Braig M, Witsch T, Wang X, et al. Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia\/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging. Circulation. 2014;130(8):676\u201387. doi: 10.1161\/CIRCULATIONAHA.113.008157 .","journal-title":"Circulation"},{"issue":"5","key":"348_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/nbm.1489","volume":"23","author":"BM Delattre","year":"2010","unstructured":"Delattre BM, Braunersreuther V, Hyacinthe JN, Crowe LA, Mach F, Vallee JP. Myocardial infarction quantification with manganese-enhanced MRI (MEMRI) in mice using a 3T clinical scanner. NMR Biomed. 2010;23(5):503\u201313. doi: 10.1002\/nbm.1489 .","journal-title":"NMR Biomed"},{"issue":"6","key":"348_CR14","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/jmri.24127","volume":"38","author":"K Skardal","year":"2013","unstructured":"Skardal K, Rolim NP, Haraldseth O, Goa PE, Thuen M. Late gadolinium enhancement in the assessment of the infarcted mouse heart: a longitudinal comparison with manganese-enhanced MRI. J Magn Reson Imaging. 2013;38(6):1388\u201394. doi: 10.1002\/jmri.24127 .","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"348_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.rli.0000153025.72638.63","volume":"40","author":"M Bruvold","year":"2005","unstructured":"Bruvold M, Nordhoy W, Anthonsen HW, Brurok H, Jynge P. Manganese-calcium interactions with contrast media for cardiac magnetic resonance imaging: a study of manganese chloride supplemented with calcium gluconate in isolated Guinea pig hearts. Investig Radiol. 2005;40(3):117\u201325.","journal-title":"Investig Radiol"},{"issue":"4","key":"348_CR16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/mrm.22071","volume":"62","author":"M Yamada","year":"2009","unstructured":"Yamada M, Gurney PT, Chung J, Kundu P, Drukker M, Smith AK, et al. Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability. Magn Reson Med. 2009;62(4):1047\u201354. doi: 10.1002\/mrm.22071 .","journal-title":"Magn Reson Med"},{"issue":"2","key":"348_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jmri.20500","volume":"23","author":"P Storey","year":"2006","unstructured":"Storey P, Chen Q, Li W, Seoane PR, Harnish PP, Fogelson L, et al. Magnetic resonance imaging of myocardial infarction using a manganese-based contrast agent (EVP 1001-1): preliminary results in a dog model. J Magn Reson Imaging. 2006;23(2):228\u201334. doi: 10.1002\/jmri.20500 .","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"348_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81294-5","volume":"84","author":"H Chen","year":"1996","unstructured":"Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db\/db mice. Cell. 1996;84(3):491\u20135.","journal-title":"Cell"},{"issue":"4","key":"348_CR19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jtcvs.2007.12.053","volume":"136","author":"SL Hendry","year":"2008","unstructured":"Hendry SL, van der Bogt KE, Sheikh AY, Arai T, Dylla SJ, Drukker M, et al. Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. J Thorac Cardiovasc Surg. 2008;136(4):1028\u20131037e1. doi: 10.1016\/j.jtcvs.2007.12.053 .","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"348_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00019501-200506000-00006","volume":"16","author":"X Xu","year":"2005","unstructured":"Xu X, Xu Z, Xu Y, Cui G. Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis. 2005;16(4):245\u201355.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"348_CR21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","volume":"95","author":"M Peichev","year":"2000","unstructured":"Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95(3):952\u20138.","journal-title":"Blood"},{"issue":"1","key":"348_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.gt.3301054","volume":"7","author":"J Gomez-Navarro","year":"2000","unstructured":"Gomez-Navarro J, Contreras JL, Arafat W, Jiang XL, Krisky D, Oligino T, et al. Genetically modified CD34\u00a0+\u00a0cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Ther. 2000;7(1):43\u201352. doi: 10.1038\/sj.gt.3301054 .","journal-title":"Gene Ther"},{"issue":"4","key":"348_CR23","first-page":"1351","volume":"20","author":"D Ribatti","year":"2005","unstructured":"Ribatti D, Nico B, Crivellato E, Vacca A. Endothelial progenitor cells in health and disease. Histol Histopathol. 2005;20(4):1351\u20138.","journal-title":"Histol Histopathol"},{"issue":"24","key":"348_CR24","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.jacc.2010.01.052","volume":"55","author":"S Heidary","year":"2010","unstructured":"Heidary S, Patel H, Chung J, Yokota H, Gupta SN, Bennett MV, et al. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. J Am Coll Cardiol. 2010;55(24):2762\u20138. doi: 10.1016\/j.jacc.2010.01.052 .","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"348_CR25","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","volume":"43","author":"M Wong","year":"2004","unstructured":"Wong M, Staszewsky L, Latini R, Barlera S, Glazer R, Aknay N, et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol. 2004;43(11):2022\u20137. doi: 10.1016\/j.jacc.2003.12.053 .","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"348_CR26","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","volume":"288","author":"HM Lakka","year":"2002","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709\u201316.","journal-title":"JAMA"},{"issue":"9644","key":"348_CR27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","volume":"372","author":"S Yusuf","year":"2008","unstructured":"Telmisartan Randomised AssessmeNt Study in ACEiswcDI, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008;372(9644):1174\u201383. doi: 10.1016\/S0140-6736(08)61242-8 .","journal-title":"Lancet"},{"issue":"3","key":"348_CR28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.110.169193","volume":"58","author":"C Endtmann","year":"2011","unstructured":"Endtmann C, Ebrahimian T, Czech T, Arfa O, Laufs U, Fritz M, et al. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension. 2011;58(3):394\u2013403. doi: 10.1161\/HYPERTENSIONAHA.110.169193 .","journal-title":"Hypertension"},{"key":"348_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2840-13-101","volume":"13","author":"N Antonio","year":"2014","unstructured":"Antonio N, Fernandes R, Soares A, Soares F, Lopes A, Carvalheiro T, et al. Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. Cardiovasc Diabetol. 2014;13:101. doi: 10.1186\/1475-2840-13-101 .","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"348_CR30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2011.06.012","volume":"410","author":"K Toyama","year":"2011","unstructured":"Toyama K, Nakamura T, Kataoka K, Yasuda O, Fukuda M, Tokutomi Y, et al. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-gamma-dependent activity. Biochem Biophys Res Commun. 2011;410(3):508\u201313. doi: 10.1016\/j.bbrc.2011.06.012 .","journal-title":"Biochem Biophys Res Commun"},{"key":"348_CR31","volume-title":"Trends in stem cell research","author":"EV Greer","year":"2005","unstructured":"Greer EV. Trends in stem cell research. New York: Nova Biomedical Books; 2005."},{"issue":"2","key":"348_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.01-0332fje","volume":"16","author":"I Inoki","year":"2002","unstructured":"Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Faseb J. 2002;16(2):219\u201321. doi: 10.1096\/fj.01-0332fje .","journal-title":"Faseb J"},{"issue":"18","key":"348_CR33","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.lfs.2004.04.024","volume":"75","author":"MA Cavasin","year":"2004","unstructured":"Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci. 2004;75(18):2181\u201392. doi: 10.1016\/j.lfs.2004.04.024 .","journal-title":"Life Sci"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0348-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:11:08Z","timestamp":1600128668000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/15\/1\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0348-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"type":"electronic","value":"1475-2840"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"article-number":"24"}}